TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

42 hedge funds and large institutions have $6.59M invested in Tvardi Therapeutics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

81% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 32

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$2K
Net Calls
Net Calls Change

Top Buyers

1
+$953K
2
+$656K
3
+$524K
4
CRC
Curi RMB Capital
Illinois
+$277K
5
UBS Group
UBS Group
Switzerland
+$48.5K

Top Sellers

1
-$524K
2
-$343K
3
-$215K
4
Bank of America
Bank of America
North Carolina
-$164K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$118K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$719
27
$594
28
$496
29
$375
30
$330
31
$283
32
$184
33
$141
34
$129
35
$122
36
$116
37
$110
38
$37
39
$20
40
$16
41
$3
42
$1
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3